Project Grant R01AG083949
Award Date
5/15/24
Completion Date
1/31/29
Dollars Obligated
$2.1M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
This $1,118,700.00 federal Project Grant award issued by the National Institute on Aging (CFDA 93.866 Aging Research) supports research at New York University (NYU) School of Medicine to investigate the disruption of endosomal microautophagy (EMI) by pathological tau protein. The research aims to elucidate the role of tau in destabilizing EMI, a key protein degradation pathway, and determine which EMI components are most vulnerable to tau pathology. Experiments will use human-derived neural...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $320,000 to the University of Texas Medical Branch at Galveston to conduct research on the role of tau protein and alternative polyadenylation (APA) in Alzheimer's disease. The study aims to comprehensively profile APA transcripts and gene expression in neurons expressing wild-type and mutant tau proteins, with the goal of better understanding how tau oligomerization impacts APA and...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Arizona State University provides $431,750 in funding to conduct research on the role of tau protein proteolysis in Alzheimer's disease. The key objectives are to: 1) test and rank the ability of tau protein peptide fragments generated by proteolysis to induce the aggregation of full-length tau protein, and 2) characterize the intracellular signaling activity of these tau peptides. Using...
This National Institute on Aging Federal Grant Award under the Aging Research program (CFDA 93.866) provides $385,000.00 to Wayne State University to investigate the role of local protein synthesis in tau pathology and neurodegeneration related to Alzheimer's disease. The project aims to determine how pathogenic forms of the tau protein specifically interfere with dendritic protein synthesis, which may contribute to the synaptic dysfunction observed in Alzheimer's disease. By leveraging tau...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $757,027 to the University of Washington to conduct research on the mechanisms underlying the synergistic relationship between tau and TDP-43 proteins in Alzheimer's disease (AD). The 5-year project, starting January 1, 2025, aims to investigate how the combination of tau and TDP-43 pathologies impairs the lysosomal autophagy pathway, which is a compensatory mechanism observed in AD. The...
The National Institute on Aging (NIA) awarded a $7,249,563 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the Regents of the University of California, San Francisco (UCSF). This 3-year award, starting on Aug 1, 2023, will support research to characterize the structural properties and variability of tau protein aggregation in different brain cell types and at different disease stages of Alzheimer's and related dementias (ADRD). The project aims to develop new...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $267,310 to the University of Washington to conduct research investigating the role of the endoplasmic reticulum unfolded protein response in tauopathy, which is associated with Alzheimer's disease. The project aims to leverage genetic approaches in C. elegans to identify molecular mechanisms in the unfolded protein response that may modulate tauopathy, as well as determine the role of...
This $431,750 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund the development and evaluation of a novel immuno-gene therapy approach for tauopathies, a group of neurodegenerative conditions including Alzheimer's disease. The key products and services to be delivered include: Generation and validation of a single-chain variable fragment (scFv) derived from a TAU oligomeric complex 1 (TOC1) antibody, coupled with a HaloTag protein and proteasome...
This federal Project Grant award of $1,671,813.00 from the National Institute on Aging's Aging Research program (CFDA 93.866) supports biophysical and pathophysiological studies of the interaction between TDP-43 and tau proteins. The University of Florida is the primary grantee, with a sub-award to Central Michigan University to provide expertise in Drosophila genetics, molecular biology, biochemistry, and microscopy to examine the role of tau and TDP-43 in neurodegenerative disease. The project...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $153,656 to The University of Iowa to investigate the reversal of tau protein pathology in serotonergic neurons as a potential therapeutic approach for early-stage Alzheimer's disease and related dementias (ADRD). The project aims to determine if directly delivering the phosphoprotein phosphatase PP2A can decrease pathogenic phosphorylated tau (p-tau) and rescue serotonergic neuron...